Amiodarone administration and acute hepatitis;Epatite acuta dopo somministrazione di amiodarone

Minerva Cardioangiologica

Volumn 45, Issue 9, 1997, Pages 451-456

  Tagliamonte, E ^a,b   Cice, G ^a   Ducceschi, V ^a   Mayer, M S ^a   Jacono, A ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b NONE   (Italy)

Author keywords

Amiodarone adverse effects; Hepatitis; Supraventricular drug therapy; Tachycardia; Toxic etiology

Indexed keywords

AMIODARONE; POLYSORBATE 80;

ACUTE HEPATITIS; ADULT; ARTICLE; CASE REPORT; DOSE RESPONSE; DOSE TIME EFFECT RELATION; DRUG MEGADOSE; DRUG WITHDRAWAL; HEART SUPRAVENTRICULAR ARRHYTHMIA; HUMAN; HUMAN CELL; HUMAN TISSUE; INTRAVENOUS DRUG ADMINISTRATION; LIVER TOXICITY; MALE;

ACUTE DISEASE; AMIODARONE; ELECTROCARDIOGRAPHY; HEPATITIS, TOXIC; HUMANS; MALE; MIDDLE AGED; TACHYCARDIA, SUPRAVENTRICULAR;

EID: 0031442124     PISSN: 00264725     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Podrid PJ. Amiodarone: reevaluation of an old drug. Ann Intern Med 1995;122:689-700.
2. Mason JW. Amiodarone toxicity study group. Toxicity of amiodarone [Abstract]. Circulation 1985;72(Suppl. III):272.
3. Zipes DP, Prystowsky EN, Heger JJ. Amiodarone: electrophysiologic actions, pharmacokinetics and clinical effects. J Am Coll Cardiol 1984;3:1059-71.
4. Wilson JS, Podrid PJ. Side effects from amiodarone. Am Heart J 1991;121:158-71.
5. Myers M, Peter T, Weiss D, Nalos PC, Gang ES, Oseran DS et al Benefit and risks of long-term amiodarone therapy for sustained ventricular Tachycardia/fibrillation, minimum of three-year follow-up in 145 patients. Am Heart J 1990;119-8-14.
6. Mason JW. Amiodarone. N Engl J Med 1987;316 455-66.
7. Nademanee K The amiodarone odyssey J Am Coll Cardiol 1992,20:1063-5.
8. Pucciarelli G, Caso P, Iacono A. Amiodarone e tiroide: a proposito di due casi di ipotiroidismo. Clin Terap 1978;84:81-4.
9. Schwartz A, Shen E, Morady F, Gillespie K, Scheinman M, Chatterjee K. Haemodinamic effects of intravenous amiodarone in patients with depressed left ventricular function and recurrent ventricular tachycardia. Am Heart J 1983;106:848-55.
10. Kosinski EJ, Albin JB, Yonug E, Lewis SM, Leland S. Haemodinamic effects of intravenous amiodarone. J Am Coll Cardiol 1984;4:565-70.
11. Remme WJ, van Hoogenhuyze DCA, Krauss XH, Hofman A, Kruyssen DACM, Storm CJ. Acute haemodinamic and antiischemic effects of intravenous amiodarone. Am J Cardiol 1985,55.639-44
12. Kadish A, Modary F The use of intravenous amiodarone in the acute therapy of life-threatening tachyan-hythmias. Prog Cardiovasc Dis 1989;31:281-94.
13. Mooss AN, Mohiuddin SM, Hee TT, Esterbrooks DJ, Hilleman DE, Rovang KS et al Efficacy and tolerance of high-dose intravenous amiodarone for recurrent, refractory ventricular tachycardia. Am J Cardiol 1990;65 609-14.
14. Nalos PC, Ismail Y, Pappas JM, Nyitray W, DonMichael TA. Intravenous amiodarone for short-term treatment refractory ventricular tachycardia or fibrillation Am Heart J 1991.122:1629-32.
15. Gough WB, Zeiler RH, Barreca P, El-Sherif N. Hypotensive action of commercial intravenous amiodarone and polysorbate 80 in dogs J Cardiovasc Farmacol 1982;4.374-80.
16. Rhodes A, Eastwood JB, Smith SA Early acute hepatitis with parenteral amiodarone a toxic effect of the vehicle? Gut 1993;34: 565-6.
17. Simon JP, Zannad F, Trechot P, Thisse JY, Houplon M, Aliot E. Acute hepatitis after a loading dose of intravenous amiodarone Cardiovasc Drug Ther 1990;4.1467-8.
18. Stevenson RNS, Nayam TH, Davies JR. Acute hepatitis dysfunction following parenteral amiodarone administration Postgrad Med J 1989;65:707-8.
19. Lupon-Roses J, Simo-Canonge R, Lu-Cortez L, Permanyer-Miralda J, Allende-Mondus H. Probable early acute hepatitis with parenteral amiodarone. Clin Cardiol 1986;9:225-9
20. Pye M, Northcote RJ, Cobbe SM. Acute hepatitis after parenteral amiodarone administration Br Heart J 1988;59:690-1.
21. Ammar A, Wong M, Singh BN Divergent effects of chronic amiodarone administration on systolic and diastolic function in patients with heart disease. Am J Cardiol 1995;75:465-9
22. Podrid PJ, Fogel RI. Aggravation of arrhythmia by antiarrhythmic drugs, and the important rule of underlying ischemia Am J Cardiol 1992;70:100-2.
23. Hohnloser SH, Klingenheben T, Singh BN. Amiodarone-associated pro arrhythmic effects. A review with special reference to Torsade de Pointes tachycardia. Ann Intern Med 1994;121.529-35
24. Vitale P, Verza M, Manzo M, Agretto A. Torsione di punta ed amiodarone Clin Ter Cardiovasc 1984; 3:129-32.
25. Rinder HM, Love JC, Wexler R. Amiodarone hepatotoxicity. N Engl J Med 1986;314:318-9.
26. Rigas B, Rosenfeld LE, Barwick KW, Enriquez R, Heizberg J, Batsford WP et al Amiodarone hepatotoxicity. A clinicopathologic study of five patients Ann Intern Med 1986;104: 348-51.
27. Poucell S., Ireton J, Valencia-Mayoral P, Downar E. Larratt L, Patterson J et al Amiodarone associated phospholipidosis and fibrosis of the liver. Light, immunohistochemical. and electron microscopic studies. Gastroenterology 1984;86:926-36.
28. Lim PK, Trewby PN, Storey GCA, Holt DW Neuropathy and fatal hepatitis in a patient receiving amiodarone. Br Med J 1984,288:1638-9.
29. Simon JB, Manley PN, Brien JF, Armstrong PW. Amiodarone hepatotoxicity simulating alcoholic liver disease. N Engl J Med 1984;311 167-72.
30. Rumessen JJ Hepatotoxicity of amiodarone Acta Med Scand 1986;219:235-9.
31. Morse RM, Valenzuela GA, Greenwald TP, Eulie PJ, Wesley RC, McCallum RW Amiodarone-induced liver toxicity. Ann Intern Med 1988;109:838-40.
32. Lewis JH, Ranrd RC, Caruso A, Jackson LH, Mullick F, Ishac KB et al. Amiodarone hepatotoxicity: prevalence and clinicopathologic correlations among 104 patients. Hepatology 1989;9:679-85.
33. Adams PC, Holt DW, Storey CA, Morley AR, Callaghan J, Campbell WF Amiodarone and its desethyl metabolite: tissue distribution and morphologic changes during long-term therapy. Circulation 1985;72:1064-75.
34. Roden DM Pharmacokinetics of amiodarone implications for drug therapy Am J Cardiol 1993,72:45F-50F.
35. Pichler WJ, Schmdler R, Staubli M, Stadler BM, de Weck AL. Anti-amiodarone antibodies detection and relationship to the development of side-effects. Am J Med 1988;85:197-202.
36. Arrowsmith JB, Faich GA, Tomita DK, Kuritsky JN, Rosa FW. Morbidity and mortality among low birth weight infants exposed to an intravenous vitamin E product, E-Ferol. Pediatrics. 1989.83.244-9.
37. Hale TW, Rais-Bahrami K, Montgomery DL, Harkey C, Habersang RW Vitamin E toxicity in neonatal piglets. J Toxicol Clin Toxicol 1995;33:123-30